Vietnam Biomedical non-woven textiles Market Size, Production, Sales, Average Product Price, Market Share
- Published 2025
- No of Pages: 120+
- 20% Customization available
Vietnam Biomedical non-woven textiles Market Revenue Size and Production Analysis
Vietnam Biomedical non-woven textiles Market Size is expected to grow at an impressive rate during the timeframe (2024-2030).
Expanding Healthcare Infrastructure and Market Dynamics
The Vietnam Biomedical non-woven textiles market has gained momentum in recent years, driven by the rapid expansion of healthcare infrastructure, government health programs, and rising patient volumes. Vietnam, with its population of nearly 100 million, is transitioning toward a more modern healthcare framework, supported by increasing budget allocations and foreign investments. In 2023, the country recorded over 20 million hospital admissions, and forecasts indicate this number could surpass 28 million by 2035 as urbanization, aging demographics, and lifestyle-related diseases intensify healthcare demand. This patient growth translates directly into higher consumption of biomedical non-woven products such as surgical gowns, protective masks, wound dressings, and hygiene disposables.
Prominent medical facilities like Bach Mai Hospital in Hanoi, Cho Ray Hospital in Ho Chi Minh City, and Hue Central Hospital have emerged as consistent demand centers for biomedical non-woven textiles. For example, Bach Mai Hospital reported more than 1.5 million outpatient visits and nearly 100,000 inpatient admissions in 2022, requiring significant volumes of disposable protective products. These institutions are setting procurement trends that influence purchasing behaviors across the entire healthcare network. For businesses, this expanding base of consumption reinforces the Vietnam Biomedical non-woven textiles market as an attractive opportunity for both domestic and international suppliers aiming to scale operations in Southeast Asia.
Chronic and Infectious Diseases Driving Demand
The Vietnam Biomedical non-woven textiles market is directly influenced by the dual burden of chronic and infectious diseases that the healthcare system must manage. Approximately 5 million people in Vietnam are living with diabetes, and forecasts suggest that this number could rise to 7.2 million by 2030. Patients with diabetes often require continuous wound management, dialysis procedures, and surgical interventions, all of which utilize non-woven medical products. Similarly, cardiovascular disease affects nearly 12 million people, generating consistent demand for surgical drapes, gowns, and disposable surgical supplies.
Infectious diseases remain another critical factor shaping demand. Vietnam reports around 170,000 tuberculosis cases annually, and forecasts estimate a potential increase of 10% over the next decade if preventive care does not expand. In addition, seasonal influenza and dengue fever outbreaks add pressure to the system, creating spikes in demand for protective masks and gowns. During the COVID-19 crisis, Vietnam saw non-woven mask sales rise nearly sixfold, and even after stabilization, hospitals continue to procure protective apparel at levels 25% above pre-pandemic averages. Cho Ray Hospital, for instance, has maintained higher procurement of disposable protective gear, citing patient safety protocols and growing surgical volumes. These disease-driven consumption patterns ensure steady growth for the Vietnam Biomedical non-woven textiles market.
Market Size, Sales Forecast, and Emerging Opportunities
The Vietnam Biomedical non-woven textiles market was valued at USD 480 million in 2024 and is projected to grow at a CAGR of 7.6%, reaching nearly USD 870 million by 2032. This trajectory reflects Vietnam’s rising healthcare spending, which currently stands at 6.5% of GDP and is expected to increase further with government commitments to universal healthcare coverage. Private sector growth also contributes significantly, with over 200 private hospitals and thousands of clinics driving procurement of biomedical non-woven supplies.
Market segmentation reveals that surgical gowns and drapes account for 37% of total sales, masks and protective apparel 33%, wound dressings 20%, and hygiene-related disposables 10%. More than 800,000 surgeries are performed annually across Vietnam, and forecasts suggest this figure could climb to 1.1 million by 2030, translating to a 30% rise in demand for surgical non-woven products. Furthermore, Vietnam is emerging as a growing medical tourism destination in Asia, with nearly 350,000 foreign patients seeking care in 2022, a number projected to reach 600,000 by 2030. Each international patient undergoing surgery or specialized treatment further boosts sales of non-woven surgical and wound care products. Together, these factors outline strong opportunities for manufacturers and marketers to capture expanding sales volumes in the Vietnam Biomedical non-woven textiles market.
Competitive Landscape and Industry Positioning
The Vietnam Biomedical non-woven textiles market is defined by competition between international corporations and domestic producers. Global leaders such as 3M, Medline Industries, and Kimberly-Clark dominate high-value segments including surgical drapes and advanced protective apparel. At the same time, Vietnamese companies like DHTI Co. Ltd. and Viet Nonwoven Joint Stock Company provide cost-effective solutions tailored to local hospital requirements. This dual presence ensures that the market benefits from both innovation and affordability.
Government initiatives have further shaped competitive dynamics. In 2022, the Ministry of Health launched a program to encourage domestic manufacturing of medical-grade non-woven masks and gowns, allocating nearly USD 100 million in incentives. As a result, local capacity has grown, reducing import dependency by 20% within two years. Hospitals such as Vinmec International Hospital and Hoan My Medical Corporation have signed agreements with both domestic and global suppliers to ensure consistent supply. For international manufacturers, partnerships with local firms represent an attractive entry point into the Vietnam Biomedical non-woven textiles market, allowing them to balance advanced technology with local cost efficiencies.
Future Outlook and Strategic Business Growth
The Vietnam Biomedical non-woven textiles market is poised for long-term growth, supported by rising patient admissions, expanding surgical procedures, and evolving procurement trends. By 2035, hospital admissions are expected to exceed 30 million annually, creating stable demand for disposable protective and surgical products. A significant trend shaping future growth is sustainability. Vietnam is implementing stricter environmental regulations, and hospitals are beginning to demand eco-friendly, biodegradable non-woven supplies. Forecasts indicate that by 2030, nearly 18% of procurement contracts in public hospitals will include sustainability criteria, encouraging manufacturers to innovate in biodegradable product lines.
Institutions like Hue Central Hospital are already piloting the use of biodegradable gowns and masks, signaling a broader transition within the procurement system. Additionally, advancements in digital supply chain solutions and predictive procurement systems are being adopted by large hospital networks, which will streamline demand forecasting for suppliers. For businesses, these trends represent not only a chance to expand sales but also an opportunity to differentiate products through innovation, sustainability, and service integration. In summary, the Vietnam Biomedical non-woven textiles market presents robust opportunities for manufacturers, distributors, and investors, offering a combination of strong demand growth, evolving hospital requirements, and favorable long-term forecasts.
Vietnam Biomedical Non-woven Textiles Market – Industrial Expansion, Healthcare Applications, and Strategic Pathways (2023–2035)
Executive Market Perspective
1.1 Overview of Biomedical Textile Utilization in Vietnam’s Healthcare System
1.2 Key Market Growth Indicators and Demand Outlook
1.3 Strategic Insights on Market Maturity and Investment Potential
National Health Strategy and Industrial Development Alignment
2.1 Ministry of Health Initiatives Promoting Medical Textiles
2.2 Government Industrialization Policies Supporting Non-woven Manufacturing
2.3 Integration of Biomedical Textiles into Public Health Programs
Market Definition, Research Scope, and Methodological Framework
3.1 Categorization of Biomedical Non-woven Textiles by Usage and Lifespan
3.2 Research Methodology, Data Validation, and Forecasting Model
Healthcare System and Consumption Channels
4.1 Central Hospitals and University-affiliated Healthcare Institutions
4.2 Private Hospitals, Specialized Clinics, and Outpatient Facilities
4.3 Primary Health Stations and Community-level Utilization
Product Segmentation and Application Spectrum
5.1 Protective Non-woven Apparel: Surgical Gowns, Masks, Drapes
5.2 Wound Care and Hygiene Products: Dressings, Bandages, Absorbent Materials
5.3 Advanced and Specialty Non-wovens: Filtration Media, Implantable Textiles
Demand Landscape by End-user
6.1 Public Healthcare Institutions and State-funded Facilities
6.2 Private Sector Healthcare Networks
6.3 Academic, Industrial, and Research-driven Applications
Technology and Product Innovation Trends
7.1 Advances in Non-woven Fabrication: Spunbond, Meltblown, SMS Technologies
7.2 Integration of Antimicrobial, Biodegradable, and Functional Coatings
Market Dynamics and Growth Potential
8.1 Drivers: Expanding Surgical Procedures, Rising Infection Control Needs, Export Growth
8.2 Constraints: Import Reliance, Cost Barriers, and Supply Chain Gaps
8.3 Opportunities: Domestic Manufacturing, Regional Trade, and Technology Transfer
Regulatory and Standards Landscape
9.1 Vietnamese Ministry of Health Guidelines and Certifications
9.2 Alignment with International Standards: ISO, ASTM, CE Markings
Procurement and Distribution Practices
10.1 Public Sector Procurement and Hospital Tendering Systems
10.2 Private Distribution Channels and Local Supplier Networks
Pricing Mechanisms and Cost Trends
11.1 Price Structures Across Key Biomedical Textile Segments
11.2 Economic Models: Volume-based Procurement and Outsourcing
Workforce and Skill Development
12.1 Training Healthcare Workers on Biomedical Textile Usage
12.2 Enhancing Technical Workforce Skills in Production and Quality Control
12.3 Continuing Professional Education for Infection Prevention
Regional Demand Patterns
13.1 Strong Market Presence in Hanoi and Ho Chi Minh City
13.2 Growing Adoption in Central and Northern Provinces
Service Infrastructure and Support Mechanisms
14.1 Vendor Support, Quality Assurance, and Sterility Management
14.2 Role of Logistics and Cold-chain in Biomedical Textile Supply
Manufacturing and Supply Chain Analysis
15.1 Domestic Manufacturing Landscape and Key Industrial Hubs
15.2 Import Channels, Material Sourcing, and Distribution Logistics
Strategic Expansion Models
16.1 Pilot Projects for Domestic Textile Innovation
16.2 Building Export-ready Industrial Clusters
Clinical and Patient-care Impact
17.1 Enhancing Surgical Safety and Hospital Hygiene Standards
17.2 Case Studies on Improved Recovery Outcomes
Sustainability and Environmental Integration
18.1 Development of Eco-friendly and Biodegradable Non-wovens
18.2 Hospital Waste Management and Recycling Initiatives
Future Market Trends and Innovations
19.1 Nanofiber Integration and Smart Textile Development
19.2 AI-driven Supply Chain and Digital Manufacturing Applications
Regional and International Collaboration
20.1 ASEAN Cooperation for Biomedical Textile Supply and Standardization
20.2 Partnerships with Global Research Institutes and Industry Leaders
Competitive Landscape and Industry Positioning
21.1 Profiles of Domestic Manufacturers and International Suppliers Active in Vietnam
21.2 Competitive Differentiation Through Cost, Innovation, and Scale
Forecasting and Market Outlook
22.1 Market Forecast by Product Type, End-user, and Region
22.2 Vietnam Biomedical Non-woven Textiles Market Outlook Through 2035
Strategic Recommendations for Stakeholders
23.1 Financing Mechanisms, Training Investments, and R&D Support
23.2 Entry Strategies for New Players and Expansion Plans for Established Firms
Benchmarking and Best Practices
24.1 Successful Implementations of Biomedical Textiles in Vietnam’s Hospitals
24.2 Key Lessons from Public-Private Collaborations
Vision 2035 – Shaping the Future of Biomedical Textiles in Vietnam
25.1 Integration with National Health and Industrial Modernization Goals
25.2 Establishing Vietnam as a Regional Hub for Biomedical Textile Manufacturing
“Every Organization is different and so are their requirements”- Datavagyanik